Skip to main content

Rhenman & Partners Asset Management AB

Position in NBIX — Neurocrine Biosciences Inc

CIK 1599882 Stockholm, V7

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,467,642
+$1,182,849 QoQ
Shares Held
85,841
-14.9% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#130
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $24,174,742 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (59.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
85,841 $14,467,642

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,467,642 85,841
2026-03-31 $13,284,793 100,841
2025-12-31 $17,798,388 125,491
2025-09-30 $16,103,972 114,717
2025-06-30 $18,755,084 149,217
2025-03-31 $9,933,760 89,817
2024-12-31 $13,693,270 100,317
2024-09-30 $8,267,035 71,750
2024-06-30 $10,401,656 75,555
2024-03-31 $8,137,280 59,000
2023-12-31 $8,169,120 62,000
2023-09-30 $6,138,675 54,566
2023-06-30 $3,772,000 40,000
2023-03-31 $7,085,400 70,000
2022-12-31 $10,152,400 85,000
2022-09-30 $8,815,430 83,000
2022-06-30 $9,260,600 95,000
2022-03-31 $9,843,750 105,000
2021-12-31 $12,869,187 151,100
2021-09-30 $9,111,450 95,000
2021-06-30 $10,218,600 105,000
2021-03-31 $15,073,750 155,000
2020-12-31 $14,377,500 150,000
2020-09-30 $7,212,000 75,000
2020-06-30 $9,150,000 75,000
2020-03-31 $11,251,500 130,000